Topics

vaccine biodistribution

A method of tracking where compounds of interest travel and where they are retained in the organs and tissues of an experimental animal or human subject receiving a vaccine; the biodistribution of a vaccine.

vaccines
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
2.4 Nonclinical Overview AZD1222
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Assessment report: COVID-19 Vaccine Moderna
Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues
Barrier Capacity of Human Placenta for Nanosized Materials
Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle Size
Biodistribution of mRNA COVID-19 vaccines in human breast milk
Cerebral venous sinus thrombosis after COVID-19 vaccination: a case report and literature review
Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2 - A Multidisciplinary Perspective
COVID Injections: Unveiling the Mechanisms of Harm
COVID Vaccine Autopsy Reports: Shocking Impact Revealed
COVID-19 mRNA “vaccine” harms research collection
COVID-19 vaccines – An Australian Review
Current state of knowledge on the excretion of mRNA and spike produced by anti-COVID-19 mRNA vaccines; possibility of contamination of the entourage of those vaccinated by these products
Detection of antibodies to SARS-CoV-2 after vaccination in seminal plasma and their association to sperm parameters
Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk
Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future Disease
Dispelling the Myth of a Pandemic of the Unvaccinated
Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients
Existing and emerging mRNA vaccines and their environmental impact: a transdisciplinary assessment
Expression of SARS-CoV-2 spike protein in cerebral Arteries: Implications for hemorrhagic stroke Post-mRNA vaccination
First case of postmortem study in a patient vaccinated against SARS-CoV-2
For “Such a Time as This”
Immunohistologic Features of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia
Inadvertent Exposure to Pharmacologically Designed Lipid Nanoparticles Via Bodily Fluids: Biologic Plausibility and Potential Consequences
Interview with Dr. William Makis
Interview: Dr. Byram Bridle Professor of Viral Immunology on Spike Protein
mRNA "vaccine" biodistribution, persistence, and adjuvant toxicity library
Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning
No evidence for TGA's mRNA safety claim
Nonclinical Evaluation Report: BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)
Pfizer/BioNTech’s COVID-19 modRNA Vaccines: Dangerous Genetic Mechanism of Action Released before Sufficient Preclinical Testing
Potential adverse effects of nanoparticles on the reproductive system
Potential Conscientious Objection to mRNA Technology as Preventive Treatment for COVID-19
Potential health risks of mRNA-based vaccine therapy: A hypothesis
Rapid Response to: Will covid-19 vaccines save lives? Current trials aren’t designed to tell us
Research Letter: Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk
Safe Nanoparticles: Are We There Yet?
SARS-CoV-2 and the Vaccination Hype
SARS-COV-2 mRNA Vaccine (BNT162, PF-07302048) — 2.6.4 Summary statement of the pharmacokinetic study
SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19
Scientific Lay Summary to Support the Letter of Concern to Prime Ministers and Governing Bodies
Severe dyskinesia after administration of SARS‐CoV2 mRNA vaccine in Parkinson’s disease
Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells
Statement by Dr. Richard Urso
Strategies for the Management of Spike Protein-Related Pathology
The COVID-19 “Vaccines”: What is the truth?
The mRNA-LNP vaccines – the good, the bad and the ugly?
The Pfizer mRNA vaccine is contaminated with the plasmid DNA vector that was used as the template for in vitro transcription reaction.
551